News

Blue Shield’s group products with infertility coverage were previously approved by the Department of Managed Health Care (DMHC) as being consistent with the requirements of SB 729. The DMHC has since issued the All Plan Letter (APL) 25-021 with additional guidance for interpreting SB 729. Blue Shield is actively assessing new requirements, engaging their clinical, regulatory, and operational teams to ensure any changes are consistent with the APL’s requirements.

Blue Shield is in the process of submitting proposed changes in coverage to the DMHC for review and approval. The DMHC is expected to issue another APL clarifying some requirements, and Blue Shield is closely monitoring the situation.

For More Information or Help Quoting Blue Shield, Please Contact Your Dickerson Sales Representative.